Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α

被引：0
|
作者：
De Ridder, K. [1 ]
Locy, H. [1 ]
Piccioni, E. [1 ]
Zuazo, M. Ibarra [2 ]
Awad, R. M. [1 ]
Verhulst, S. [3 ,4 ]
van Bulck, M. [5 ]
De Vlaeminck, Y. [1 ]
Lecocq, Q. [1 ]
Reijmen, E. [1 ]
De Mey, W. [1 ]
De Beck, L.
Ertveldt, T. [1 ]
Pintelon, I. [6 ]
Timmermans, J-P. [6 ]
Escors, D. [2 ]
Keyaerts, M. [7 ]
Breckpot, K. [1 ]
Goyvaerts, C. [1 ]
机构：
[1] Vrije Univ Brussel, Fac Med & Pharm, Dept Biomed Sci, Lab Mol & Cellular Therapy, Brussels, Belgium
[2] Navarrabiomed UPNA IdISNA, Immunomodulat Grp, Pamplona, Spain
[3] Dept Biomed Sci, Brussels, Belgium
[4] Liver Cell Biol Res Grp, Jette, Belgium
[5] Vrije Univ Brussel, Dept Biomed Sci, Lab Mol & Med Oncol, Jette, Belgium
[6] Univ Antwerp, Antwerp Ctr Adv Microscopy ACAM, Lab Cell Biol & Histol, Antwerp, Belgium
[7] Vrije Univ Brussel, Fac Med & Pharm, Invivo Cellular & Mol Imaging Lab, Jette, Belgium
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.200
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
168P
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [1] TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy
    De Ridder, Kirsten
    Locy, Hanne
    Piccioni, Elisa
    Zuazo, Miren Ibarra
    Awad, Robin Maximilian
    Verhulst, Stefaan
    Van Bulck, Mathias
    De Vlaeminck, Yannick
    Lecocq, Quentin
    Reijmen, Eva
    De Mey, Wout
    De Beck, Lien
    Ertveldt, Thomas
    Pintelon, Isabel
    Timmermans, Jean-Pierre
    Escors, David
    Keyaerts, Marleen
    Breckpot, Karine
    Goyvaerts, Cleo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Jiming Chen
    Jie Yang
    Wenhui Wang
    Danfeng Guo
    Chengyan Zhang
    Shibo Wang
    Xinliang Lu
    Xiaofang Huang
    Pingli Wang
    Gensheng Zhang
    Jing Zhang
    Jianli Wang
    Zhijian Cai
    Cellular & Molecular Immunology, 2022, 19 : 1290 - 1301
  • [3] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Chen, Jiming
    Yang, Jie
    Wang, Wenhui
    Guo, Danfeng
    Zhang, Chengyan
    Wang, Shibo
    Lu, Xinliang
    Huang, Xiaofang
    Wang, Pingli
    Zhang, Gensheng
    Zhang, Jing
    Wang, Jianli
    Cai, Zhijian
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1290 - 1301
  • [4] Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment
    Zhang, Hongyu
    Huang, Hao
    Wu, Shaoxian
    He, Xian
    Chen, Junjun
    Zheng, Xiao
    Chen, Lujun
    Wang, Zhigang
    MEDICAL ONCOLOGY, 2023, 40 (10)
  • [5] Single-cell RNA sequencing reveals the effects of anti-PD-L1 therapy on 3LL lung cancer model and its tumor microenvironment
    Hongyu Zhang
    Hao Huang
    Shaoxian Wu
    Xian He
    Junjun Chen
    Xiao Zheng
    Lujun Chen
    Zhigang Wang
    Medical Oncology, 40
  • [6] Remodeling of the Tumor Microenvironment by a Chemokine/Anti-PD-L1 Nanobody Fusion Protein
    Fang, Tao
    Li, Ran
    Li, Zeyang
    Cho, Julia
    Guzman, Jonathan S.
    Kamm, Roger D.
    Ploegh, Hidde L.
    MOLECULAR PHARMACEUTICS, 2019, 16 (06) : 2838 - 2844
  • [7] Degradation of hyaluronan in the tumor microenvironment enhances oncolytic reovirus and anti-PD-L1 therapy in a murine syngeneic breast tumor model
    Lee, Jisook
    Wilkinson, Grey A.
    Kimbler, Trevor
    Blouw, Barbara
    Thompson, Curtis B.
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Cimetidine Attenuates Therapeutic Effect of Anti-PD-1 and Anti-PD-L1 and Modulates Tumor Microenvironment in Colon Cancer
    Kuo, Feng-Chi
    Lai, Jerry Cheng-Yen
    Shieh, Hui-Ru
    Liou, Wan-Zu
    Bair, Ming-Jong
    Chen, Yu-Jen
    BIOMEDICINES, 2024, 12 (03)
  • [9] Development and Characterization of an Anti-PD-L1 Immunotoxin for Targeted Cancer Therapy
    Takhteh, Ali
    Hosseininejad-Chafi, Mohammad
    Oghalaie, Akbar
    Behdani, Mahdi
    Kazemi-Lomedasht, Fatemeh
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [10] Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
    Liu, Kefang
    Tan, Shuguang
    Chai, Yan
    Chen, Danqing
    Song, Hao
    Zhang, Catherine Wei-Hong
    Shi, Yi
    Liu, Jun
    Tan, Wenjie
    Lyu, Jianxin
    Gao, Shan
    Yan, Jinghua
    Qi, Jianxun
    Gao, George F.
    CELL RESEARCH, 2017, 27 (01) : 151 - 153
12345